• 1
    Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 2002; 61: 97580.
  • 2
    Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996; 39: 178190.
  • 3
    Pap T, van der Laan WH, Aupperle KR, Gay RE, Verheijen JH, Firestein GS, et al. Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis. Arthritis Rheum 2000; 43: 25316.
  • 4
    Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M, et al. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 1998; 152: 10918.
  • 5
    Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 2002; 99: 1392631.
  • 6
    Lee YH, Choi SJ, Kim A, Kim CH, Ji JD, Song GG. Expression of cyclooxygenase-1 and -2 in rheumatoid arthritis synovium. J Korean Med Sci 2000; 15: 8892.
  • 7
    Siegle I, Klein T, Backman JT, Saal JG, Nusing RM, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 1998; 41: 1229.
  • 8
    Kang RY, Freire-Moar J, Sigal E, Chu CQ. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br J Rheumatol 1996; 35: 7118.
  • 9
    Robinson DR, McGuire MB, Levine L. Prostaglandins in the rheumatic diseases. Ann N Y Acad Sci 1975; 256: 31829.
  • 10
    Robinson DR, Dayer JM, Krane SM. Prostaglandins and their regulation in rheumatoid inflammation. Ann N Y Acad Sci 1979; 332: 27994.
  • 11
    Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997; 388: 67882.
  • 12
    Falchuk KH, Goetzl EJ, Kulka JP. Respiratory gases of synovial fluids: an approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis. Am J Med 1970; 49: 22331.
  • 13
    Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum 1970; 13: 76976.
  • 14
    Ellis G, Edmonds SE, Gaffney K, Williams RB. Synovial tissue oxygenation profile in inflamed and non-inflamed knee joints [abstract]. Br J Rheumatol 1994; 33 Suppl 1: 172.
  • 15
    Mapp PI, Grootveld MC, Blake DR. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 1995; 51: 41936.
  • 16
    Demasi M, Cleland LG, Cook-Johnson RJ, Caughey GE, James MJ. Effects of hypoxia on monocyte inflammatory mediator production: dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis. J Biol Chem 2003; 278: 3860716.
  • 17
    Neidhart M, Seemayer CA, Hummel KM, Michel BA, Gay RE, Gay S. Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: destructive potential in vitro and in vivo. Arthritis Rheum 2003; 48: 187380.
  • 18
    Pouliot M, Baillargeon J, Lee JC, Cleland LG, James MJ. Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase. J Immunol 1997; 158: 49307.
  • 19
    Meade EA, McIntyre TM, Zimmerman GA, Prescott SM. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 1999; 274: 832834.
  • 20
    Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997; 272: 6018.
  • 21
    Barrios-Rodiles M, Tiraloche G, Chadee K. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1β and TNF-α. J Immunol 1999; 163: 9639.
  • 22
    Caughey GE, Cleland LG, Gamble JR, James MJ. Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets: role of thromboxane A2. J Biol Chem 2001; 276: 3783945.
  • 23
    Dingle J, Page-Thomas D. In vitro studies on human synovial membrane: a metabolic comparison of normal and rheumatoid tissue. Br J Exp Pathol 1956; 37: 31823.
  • 24
    Naughton D, Whelan M, Smith EC, Williams R, Blake DR, Grootveld M. An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy. FEBS Lett 1993; 317: 1358.
  • 25
    Geborek P, Forslind K, Wollheim FA. Direct assessment of synovial blood flow and its relation to induced hydrostatic pressure changes. Ann Rheum Dis 1989; 48: 2816.
  • 26
    James MJ, Cleland LG, Rofe AM, Leslie AL. Intraarticular pressure and the relationship between synovial perfusion and metabolic demand. J Rheumatol 1990; 17: 5217.
  • 27
    Cok SJ, Morrison AR. The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem 2001; 276: 2317985.
  • 28
    Kruys V, Marinx O, Shaw G, Deschamps J, Huez G. Translational blockade imposed by cytokine-derived UA-rich sequences. Science 1989; 245: 8525.
  • 29
    Akashi M, Shaw G, Hachiya M, Elstner E, Suzuki G, Koeffler P. Number and location of AUUUA motifs: role in regulating transiently expressed RNAs. Blood 1994; 83: 31827.
  • 30
    Pulkki KJ, Eerola ET, Saario RM, Toivanen A, Vuorio EI. Activated monocytes induce arthritis-associated changes in mitochondria of cultured synovial fibroblasts. Scand J Rheumatol 1988; 17: 13141.
  • 31
    Scott BB, Weisbrot LM, Greenwood JD, Bogoch ER, Paige CJ, Keystone EC. Rheumatoid arthritis synovial fibroblast and U937 macrophage/monocyte cell line interaction in cartilage degradation. Arthritis Rheum 1997; 40: 4908.
  • 32
    Chen V, Croft D, Purkis P, Kramer IM. Co-culture of synovial fibroblasts and differentiated U937 cells is sufficient for high interleukin-6 but not interleukin-1β or tumour necrosis factor-α release. Br J Rheumatol 1998; 37: 14856.
  • 33
    Elias JA, Gustilo K, Freundlich B. Human alveolar macrophage and blood monocyte inhibition of fibroblast proliferation: evidence for synergy between interleukin-1 and tumor necrosis factor. Am Rev Respir Dis 1988; 138: 1595603.
  • 34
    Ishikawa H, Ohno O, Saura R, Matsubara T, Kuroda T, Hirohata K. Cytokine enhancement of monocyte/synovial cell attachment to the surface of cartilage: a possible trigger of pannus formation in arthritis. Rheumatol Int 1991; 11: 316.
  • 35
    Khalkhali-Ellis Z, Seftor EA, Nieva DR, Seftor RE, Samaha HA, Bultman L, et al. Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell population. J Rheumatol 1997; 24: 245160.
  • 36
    Wharton W. Human macrophage-like cell line U937-1 elaborates mitogenic activity for fibroblasts. J Reticuloendothel Soc 1983; 33: 1516.
  • 37
    Janusz MJ, Hare M. Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines: a model of metalloproteinase-mediated connective tissue degradation. J Immunol 1993; 150: 192231.
  • 38
    Hamilton JA, Clarris BJ, Fraser JR, Niall MC. Peripheral blood mononuclear cells stimulate prostacyclin levels of human synovial fibroblast-like cells. Rheumatol Int 1985; 5: 1215.
  • 39
    Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 214914.
  • 40
    Jovanovic DV, Mineau F, Notoya K, Reboul P, Martel-Pelletier J, Pelletier JP. Nitric oxide induced cell death in human osteoarthritic synoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and/or superoxide formation. J Rheumatol 2002; 29: 216575.
  • 41
    Adderley SR, Fitzgerald DJ. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem 1999; 274: 503846.
  • 42
    Chang YW, Jakobi R, McGinty A, Foschi M, Dunn MJ, Sorokin A. Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity. Mol Cell Biol 2000; 20: 85719.
  • 43
    Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, et al. P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J 2002; 21: 563544.
  • 44
    Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493501.
  • 45
    Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58: 3626.
  • 46
    Yun JK, McCormick TS, Villabona C, Judware RR, Espinosa MB, Lapetina EG. Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia. Proc Natl Acad Sci U S A 1997; 94: 139038.